4.9(top 5%)
impact factor
3.0K(top 10%)
papers
78.0K(top 5%)
citations
103(top 5%)
h-index
5.0(top 5%)
impact factor
3.4K
all documents
83.0K
doc citations
152(top 5%)
g-index

Top Articles

#TitleJournalYearCitations
1State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016–2018Diabetes Technology and Therapeutics20191,332
2The Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring SystemDiabetes Technology and Therapeutics2015547
3Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 DiabetesDiabetes Technology and Therapeutics2017481
4Continuous Glucose Monitoring: A Review of Successes, Challenges, and OpportunitiesDiabetes Technology and Therapeutics2016454
5WellDoc™ Mobile Diabetes Management Randomized Controlled Trial: Change in Clinical and Behavioral Outcomes and Patient and Physician SatisfactionDiabetes Technology and Therapeutics2008377
6Correlation Between Sweat Glucose and Blood Glucose in Subjects with DiabetesDiabetes Technology and Therapeutics2012375
7MINMOD Millennium: A Computer Program to Calculate Glucose Effectiveness and Insulin Sensitivity from the Frequently Sampled Intravenous Glucose Tolerance TestDiabetes Technology and Therapeutics2003372
8Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic OutcomesDiabetes Technology and Therapeutics2017306
9The Relationship of Hemoglobin A1C to Time-in-Range in Patients with DiabetesDiabetes Technology and Therapeutics2019302
10A Novel Approach to Continuous Glucose Analysis Utilizing Glycemic VariationDiabetes Technology and Therapeutics2005299
11Normal Reference Range for Mean Tissue Glucose and Glycemic Variability Derived from Continuous Glucose Monitoring for Subjects Without Diabetes in Different Ethnic GroupsDiabetes Technology and Therapeutics2011279
12Performance Evaluation of the MiniMed® Continuous Glucose Monitoring System During Patient Home UseDiabetes Technology and Therapeutics2000268
13A Tale of Two Compartments: Interstitial Versus Blood Glucose MonitoringDiabetes Technology and Therapeutics2009266
14Sensor-Augmented Insulin Pump Therapy: Results of the First Randomized Treat-to-Target StudyDiabetes Technology and Therapeutics2008263
15A Critical Assessment of Algorithms and Challenges in the Development of a Closed-Loop Artificial PancreasDiabetes Technology and Therapeutics2005245
16The MiniMed Continuous Glucose Monitoring SystemDiabetes Technology and Therapeutics2000243
17Interpretation of Continuous Glucose Monitoring Data: Glycemic Variability and Quality of Glycemic ControlDiabetes Technology and Therapeutics2009242
18Computerized Automated Reminder Diabetes System (CARDS): E-Mail and SMS Cell Phone Text Messaging Reminders to Support Diabetes ManagementDiabetes Technology and Therapeutics2009242
19Artificial Neural Network Algorithm for Online Glucose Prediction from Continuous Glucose MonitoringDiabetes Technology and Therapeutics2010240
20Sudoscan, a Noninvasive Tool for Detecting Diabetic Small Fiber Neuropathy and Autonomic DysfunctionDiabetes Technology and Therapeutics2013221
21Variability of Insulin Absorption and Insulin ActionDiabetes Technology and Therapeutics2002216
22Non-Invasive Glucose Measurement Technologies: An Update from 1999 to the Dawn of the New MillenniumDiabetes Technology and Therapeutics2004211
23Associations Between Health Literacy, Diabetes Knowledge, Self-Care Behaviors, and Glycemic Control in a Low Income Population with Type 2 DiabetesDiabetes Technology and Therapeutics2011210
24Encapsulation of Exenatide in Poly-(d,l-Lactide-Co-Glycolide) Microspheres Produced an Investigational Long-Acting Once-Weekly Formulation for Type 2 DiabetesDiabetes Technology and Therapeutics2011208
25Minimally Invasive Extraction of Dermal Interstitial Fluid for Glucose Monitoring Using MicroneedlesDiabetes Technology and Therapeutics2005198
26New and Improved Methods to Characterize Glycemic Variability Using Continuous Glucose MonitoringDiabetes Technology and Therapeutics2009193
27The Original Clarke Error Grid Analysis (EGA)Diabetes Technology and Therapeutics2005191
28Statistical Tools to Analyze Continuous Glucose Monitor DataDiabetes Technology and Therapeutics2009190
29The Development and Validation of the Norfolk QOL-DN, a New Measure of Patients' Perception of the Effects of Diabetes and Diabetic NeuropathyDiabetes Technology and Therapeutics2005189
30α-Lipoic Acid: A Multifunctional Antioxidant That Improves Insulin Sensitivity in Patients with Type 2 DiabetesDiabetes Technology and Therapeutics2000184
31Optimal Sampling Duration for Continuous Glucose Monitoring to Determine Long-Term Glycemic ControlDiabetes Technology and Therapeutics2018180
32Can Interstitial Glucose Assessment Replace Blood Glucose Measurements?Diabetes Technology and Therapeutics2000175
33Breath Ethanol and Acetone as Indicators of Serum Glucose Levels: An Initial ReportDiabetes Technology and Therapeutics2005173
34A Continuous Glucose Sensor Based on Wired Enzyme™ Technology - Results from a 3-Day Trial in Patients with Type 1 DiabetesDiabetes Technology and Therapeutics2003172
35Assessing Sensor Accuracy for Non-Adjunct Use of Continuous Glucose MonitoringDiabetes Technology and Therapeutics2015171
36Quantifying Temporal Glucose Variability in Diabetes via Continuous Glucose Monitoring: Mathematical Methods and Clinical ApplicationDiabetes Technology and Therapeutics2005169
37High-Sensitivity C-Reactive Protein as Cardiovascular Risk Marker in Patients with Diabetes MellitusDiabetes Technology and Therapeutics2006167
38Ethnic-Specific Criteria for Classification of Body Mass Index: A Perspective for Asian Indians and American Diabetes Association Position StatementDiabetes Technology and Therapeutics2015167
39Alarms Based on Real-Time Sensor Glucose Values Alert Patients to Hypo- and Hyperglycemia: The Guardian Continuous Monitoring SystemDiabetes Technology and Therapeutics2004166
40Skin Autofluorescence, a Novel Marker for Glycemic and Oxidative Stress-Derived Advanced Glycation Endproducts: An Overview of Current Clinical Studies, Evidence, and LimitationsDiabetes Technology and Therapeutics2006163
41System Accuracy Evaluation of 27 Blood Glucose Monitoring Systems According to DIN EN ISO 15197Diabetes Technology and Therapeutics2010160
42Safety Evaluation of the MiniMed 670G System in Children 7–13 Years of Age with Type 1 DiabetesDiabetes Technology and Therapeutics2019155
43Serum 1,5-Anhydroglucitol (GlycoMark™): A Short-Term Glycemic MarkerDiabetes Technology and Therapeutics2003154
44Characterizing Glucose Exposure for Individuals with Normal Glucose Tolerance Using Continuous Glucose Monitoring and Ambulatory Glucose Profile AnalysisDiabetes Technology and Therapeutics2008154
45Reduction in Hemoglobin A1c with Real-Time Continuous Glucose Monitoring: Results from a 12-Week Observational StudyDiabetes Technology and Therapeutics2007149
46Reference Values of Skin AutofluorescenceDiabetes Technology and Therapeutics2010148
47Time in Range Is Associated with Carotid Intima-Media Thickness in Type 2 DiabetesDiabetes Technology and Therapeutics2020148
48Minimally Invasive Insulin Delivery in Subjects with Type 1 Diabetes Using Hollow MicroneedlesDiabetes Technology and Therapeutics2009147
49The Contribution of Glucose Variability to Asymptomatic Hypoglycemia in Persons with Type 2 DiabetesDiabetes Technology and Therapeutics2011147
50EXUBERA®: Pharmaceutical Development of a Novel Product for Pulmonary Delivery of InsulinDiabetes Technology and Therapeutics2005146